Celldex Therapeutics Inc
NASDAQ:CLDX
Wall Street
Price Targets
CLDX Price Targets Summary
Celldex Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CLDX
is 72.13 USD
with a low forecast of 35.35 USD and a high forecast of 94.5 USD.
CLDX Last Price Targets
Celldex Therapeutics Inc
The latest public price target was made on Nov 10, 2023 by
Derek Archila
from
Wells Fargo
,
who expects
CLDX
stock to
drop by 34%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Derek Archila
Wells Fargo
|
27
USD
Downside 34% |
5 months ago
Nov 10, 2023
|
Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLDX's stock price target?
Price Target
72.13
USD
According to Wall Street analysts, the average 1-year price target for
CLDX
is 72.13 USD
with a low forecast of 35.35 USD and a high forecast of 94.5 USD.
What is Celldex Therapeutics Inc's Revenue forecast?
Projected CAGR
-22%
For the last 8 years the
compound annual growth rate for
Celldex Therapeutics Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
-22%.
You don't have any saved screeners yet
